Clinical trial Recruiting at 1 site Phase2; Phase3 Interventional Ages 18 and up

Nonopioid pain management after shoulder surgery

Official title: Traditional vs. Nonopioid Analgesia After Labral Surgery

Run by Henry Ford Health System · NCT03825809 · Data updated 2026-11-12

This study tests whether a nonopioid pain management approach can help adults recovering from shoulder surgery feel less pain compared to the usual opioid treatment.

Quick facts

PhasePhase2; Phase3
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorHenry Ford Health System
Academic / other
Locations1 site (Detroit, Michigan)
StatusRecruiting
StartedJanuary 22, 2019
Main results expectedJanuary 20, 2020
Study endsMay 20, 2020
Registry record updatedJanuary 31, 2019
Trial IDNCT03825809 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 scheduled for primary or revision labral surgery.

Probably not a fit

Patients with a history of narcotic use within the last 6 months or those with specific medical conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial compares postoperative pain control in patients undergoing rotator cuff repair by evaluating two treatment approaches: a nonopioid pain control regimen and a standard opioid pain control regimen. Adult patients over 18 years old who are scheduled for primary or revision labral surgery will be randomly assigned to one of the two groups. Pain levels will be assessed using a visual analog scale (VAS) and PROMIS metrics at various postoperative intervals. The study aims to determine the effectiveness of nonopioid analgesia in managing pain after surgery.

Why it matters

Potential benefit: If successful, this study could provide an effective nonopioid alternative for pain management, reducing reliance on narcotics post-surgery.

How similar studies have gone: Previous studies have shown promise in using nonopioid analgesics for pain management in similar surgical contexts, suggesting potential success for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Eligibility Criteria:

Inclusion Criteria:

* All adult patients over age 18 and scheduled for a primary or revision labral surgery

Exclusion Criteria:

* Exclusion criteria will include patients with a medical history of known allergies or intolerance to allergies or intolerance to Celebrex, Tylenol, Neurontin, dexamethasone, tramadol, substantial alcohol or drug abuse, and pregnancy, history of narcotics within 6 months of surgery, renal impairment, peptic ulcer disease, GI bleeding. Secondary exclusion criterion is an intact rotator cuff

Where it's running

  • Henry Ford Health System
    Detroit, Michigan, United States
    Recruiting

Study contacts

  • Principal investigator: Toufic R Jildeh, MD — Henry Ford Health System
  • Study coordinator: Toufic R Jildeh, MD
  • Email: tjildeh1@hfhs.org
  • Phone: 517-230-8511

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.